APA (7th ed.) Citation

Poveda, A., Lheureux, S., Colombo, N., Cibula, D., Lindemann, K., Weberpals, J., . . . Škof, E. (2022). Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1/BRCA2 mutation: OPINION primary analysis. Gynecologic Oncology, 164(3), 498. https://doi.org/10.1016/j.ygyno.2021.12.025

Chicago Style (17th ed.) Citation

Poveda, A., et al. "Olaparib Maintenance Monotherapy in Platinum-sensitive Relapsed Ovarian Cancer Patients Without a Germline BRCA1/BRCA2 Mutation: OPINION Primary Analysis." Gynecologic Oncology 164, no. 3 (2022): 498. https://doi.org/10.1016/j.ygyno.2021.12.025.

MLA (9th ed.) Citation

Poveda, A., et al. "Olaparib Maintenance Monotherapy in Platinum-sensitive Relapsed Ovarian Cancer Patients Without a Germline BRCA1/BRCA2 Mutation: OPINION Primary Analysis." Gynecologic Oncology, vol. 164, no. 3, 2022, p. 498, https://doi.org/10.1016/j.ygyno.2021.12.025.